Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARP: Hydroxychloroquine in PBD-ZSD
NCT03856866Phase 2Completed
- Sponsor
- SickKids
- Start
- Jan 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in Peroxisome biogenesis disorders (PBDs), sponsored by SickKids. Started Jan 2019; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
Peroxisome biogenesis disorders (PBDs)
Beyond the preview
Go deeper on NCT03856866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03856866.